Reversal of Adrenergic Desensitization in Prenatally Stressed Rats by P38 Map Kinase Inhibitor, SB203580

被引：0
|
作者：
Chen, Fangping [1 ]
Kan, Hong [1 ]
Xie, Sherry [1 ]
Beto, Robert J. [1 ]
Warden, Bradford E. [1 ]
Jain, Abnash C. [1 ]
Finkel, Mitchell S. [1 ,2 ]
机构：
[1] W Virginia Univ, Morgantown, WV 26506 USA
[2] Louis A Johnson VA Med Ctr, Clarksburg, WV USA
来源：
FASEB JOURNAL | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580
    Sumida, T
    Otani, H
    Kyoi, S
    Okada, T
    Fujiwara, H
    Nakao, Y
    Kido, M
    Imamura, H
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (06): : H2726 - H2734
  • [22] The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway
    Birkenkamp, KU
    Tuyt, LML
    Lummen, C
    Wierenga, LTJ
    Kruijer, W
    Vellenga, E
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (01) : 99 - 107
  • [23] Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580
    Koranteng, RD
    Swindle, EJ
    Davis, BJ
    Dearman, RJ
    Kimber, I
    Flanagan, BF
    Coleman, JW
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (01): : 81 - 87
  • [24] P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production
    Lahti, A
    Kankaanranta, H
    Moilanen, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 454 (2-3) : 115 - 123
  • [25] The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages
    Shi, Qinghai
    Cheng, Liping
    Liu, Zhengxiang
    Hu, Keyan
    Ran, Jihua
    Ge, Di
    Fu, Jianfeng
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 40 (03) : 276 - 282
  • [26] Quantitative proteomic and transcriptional analysis of the response to the p38 mitogen-activated protein kinase inhibitor SB203580 in transformed follicular lymphoma cells
    Lin, ZS
    Crockett, DK
    Jenson, SD
    Lim, MS
    Elenitoba-Johnson, KSJ
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (08) : 820 - 833
  • [27] p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats
    Nuttikarn Nokkaew
    Podsawee Mongkolpathumrat
    Ruttanapong Junsiri
    Supawit Jindaluang
    Nichagron Tualamun
    Niya Manphatthanakan
    Nareumon Saleesee
    Marisa Intasang
    Jantira Sanit
    Punyanuch Adulyaritthikul
    Kantapich Kongpol
    Sarawut Kumphune
    Nitirut Nernpermpisooth
    Indian Journal of Clinical Biochemistry, 2021, 36 : 228 - 234
  • [28] Protective effects of the p38 MAPK inhibitor SB203580 on NMDA-induced injury in primary cerebral cortical neurons
    Liu, Xue-Wen
    Ji, En-Fei
    He, Peng
    Xing, Rui-Xian
    Tian, Bu-Xian
    Li, Xi-Dong
    MOLECULAR MEDICINE REPORTS, 2014, 10 (04) : 1942 - 1948
  • [29] p38 MAPK Inhibitor (SB203580) and Metformin Reduces Aortic Protein Carbonyl and Inflammation in Non-obese Type 2 Diabetic Rats
    Nokkaew, Nuttikarn
    Mongkolpathumrat, Podsawee
    Junsiri, Ruttanapong
    Jindaluang, Supawit
    Tualamun, Nichagron
    Manphatthanakan, Niya
    Saleesee, Nareumon
    Intasang, Marisa
    Sanit, Jantira
    Adulyaritthikul, Punyanuch
    Kongpol, Kantapich
    Kumphune, Sarawut
    Nernpermpisooth, Nitirut
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2021, 36 (02) : 228 - 234
  • [30] Differential effects of p38 MAP kinase inhibitors SB203580 and SB202190 on growth and migration of human MDA-MB-231 cancer cell line
    Duzgun, Sukru Aydin
    Yerlikaya, Azmi
    Zeren, Sezgin
    Bayhan, Zulfu
    Okur, Emrah
    Boyaci, Ihsan
    CYTOTECHNOLOGY, 2017, 69 (04) : 711 - 724
12345